Brief: U.S. Food And Drug Administration Approves Biomarin's Palynziq® (Pegvaliase-Pqpz) For Adolescents 12 Years Of Age And Older With Phenylketonuria (Pku)
28/02/2026 01:02
Feb 27 (Reuters) - Biomarin Pharmaceutical Inc BMRN.O: U.S. FOOD AND DRUG ADMINISTRATION APPROVES BIOMARIN'S PALYNZIQ® (PEGVALIASE-PQPZ) FOR ADOLESCENTS 12 YEARS OF AGE AND OLDER WITH PHENYLKETONURIA (PKU) Source text: ID:nPn6FvHL4a Further company coverage: BMRN.O ((Reuters.Briefs@thomsonreuters.com;))
Recent news on BioMarin Pharmaceutical
See all newsUS RESEARCH ROUNDUP-Analog Devices, IBM, Qualcomm
Brief: Biomarin Pharmaceutical Expects Q3 2026 Pre-Tax Charges Of $283 Million For Bought Ipr&D Expense
Brief: Biomarin Appoints Cara Bauer As Chief People Officer
Brief: Biomarin Pharmaceutical Enters Settlement And License Agreement With Ascendis Pharma On Sept 24, 2026
U.S. STOCKS ON THE MOVE-GitLab, California utilities, Herbalife